Clinical impact of nephropathy induced by contrast medium in patients with acute myocardial infarction undergoing emergent coronary angiography

Journal of Cardiology

Volumn 48, Issue 1, 2006, Pages 9-16

  Jujo, Kentaro ^a   Yamaguchi, Junichi ^a   Obayashi, Kenji ^a   Suzuki, Kaori ^a   Sekiguchi, Haruki ^a   Nagashima, Michitaka ^a   Tsurumi, Yukio ^a   Kasanuki, Hiroshi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiocardiography; Contrast media; Myocardial infarction; Prognosis; Renal function (nephropathy); Treatment

Indexed keywords

CONTRAST MEDIUM; CREATININE; IOPAMIDOL;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; EMERGENCY; FEMALE; HEART INFARCTION; HUMAN; KIDNEY DISEASE; MALE; MIDDLE AGED; MORTALITY; PREDICTION AND FORECASTING; PROGNOSIS; RADIOGRAPHY;

AGED; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CREATININE; EMERGENCIES; FEMALE; HOSPITAL MORTALITY; HUMANS; IOPAMIDOL; KIDNEY DISEASES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 33747449553     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Le May MR, Labinaz M, Davies RF, Marquis JF, Laramee LA, O'Brien ER, Williams \VL, Beanlands RS, Nichol G, Higginson LA: Stenting versus thrombolysis in acute myocardial infarction trial (STAT). J Am Coll Cardiol 2001; 37: 985-991
2. Kasanuki H, Honda T, Haze K, Sumiyoshi T, Horie T, Yagi M, Yamaguchi J, Ishii Y, Fujii S, Nagashima M, Okada H, Koganei H, Koyanagi R, Tsurumi Y, Kimura H, Ogawa H; HIJAMI Investigators: A large-scale prospective cohort study on the current status of therapeutic modal- ities for acute myocardial infarction in Japan: Rationale and initial results of the HIJAMI Registry. Am Heart J 2005; 150:411-418
3. Cavusoglu E, Chhabra S, Marmur JD, Kini A, Sharma SK: The prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention. Minerva Cardioangiol2004; 52: 419-432
4. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill \V\V: Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Medl997; 103: 368-375
5. Best PJ, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR, Berger PB: The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2002; 39: 1113-1119
6. Marenzi G, Lauri G, Assanelli E, Campodonico J, De Metrio M, Marana I, Grazi M, Veglia F, Bartorelli AL: Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004; 44: 1780-1785
7. Gillum RF, Fortmann SP, Prineas RJ, Kottke TE: International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J 1984 ; 108: 150-158
8. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA: Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med2004; 351: 1285-1295
9. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Bareness GW, Mathew V, Garratt KN, Holmes DR Jr: Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105: 2259-2264
10. Ueda J, Nygren A, Hansell P, Ulfendahl HR: Effect of intravenous contrast media on proximal and distal tubular hydrostatic pressure in the rat kidney. Acta Radiol 1993; 34: 83-87
11. Battenfeld R, Khater A el-R, Drommer W, Guenzel P, Kaup FJ: Ioxaglate-induced light and electron microscopic alterations in the renal proximal tubular epithelium of rats. Invest Radiol 1991; 26: 35-39
12. Katholi RE, Woods WT Jr, Taylor GJ, Deitrick CL, Womack KA, Katholi CR, McCann WP: Oxygen free radicals and contrast nephropathy. Am J Kidney Dis 1998; 32: 64-71
13. Hizoh I, Haller C: Radiocontrast-induced renal tubular cell apoptosis: Hypertonic versus oxidative stress. Invest Radiol 2002; 37: 428-434
14. MuCullough PA, Sandberg KR: Epidemiology of contrast-induced nephropathy. Rev Cardiovasc Med 2003; 4(Suppl 5): S3-S9
15. Han YL, Zang HY, Jing QM, Wang SL, Wang DM, Wang ZL: Protection of renal function during interventional diagnostic or therapeutic procedures in coronary heart disease patients complicated by chronic renal insufficiency. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2004; 16: 530-532 (in Chinese with Eng abstr)
16. Yamaguchi J, Kasanuki H, Ishii Y, Yagi M, Ogawa H, Fujii S, Koganei H, Okada H, Kimura H, Hone T, Haze K, Sumiyoshi T, Honda T; HIJC Study Group: Prognostic significance of serum creatinine concentration for in-hospi-tal mortality in patients with acute myocardial infarction who underwent successful primary percutaneous coronary intervention (from the Heart Institute of Japan Acute Myocardial Infarction [HIJAMI] Registry). Am J Caldiol 2004; 93: 1526-1528
17. Kapoor A, Kumar S, Gulati S, Gambhir S, Sethi RS, Sinha N: The role of theophylline in contrast-induced nephropathy: A case-control study. Nephrol Dial Transplant 2002; 17: 1936-1941
18. Erley CM, Duda SH, Rehfuss D, Scholtes B, Bock J, Muller C, Osswald H, Risler T: Prevention of radiocon-trast-media-induced nephropathy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline. Nephrol Dial Transplant 1999; 14: 1146-1149
19. Hans SS, Hans BA, Dhillon R, Dmuchowski C, Glover J: Effect of dopamine on tenal function after arteriography in patients with pre-existing renal insufficiency. Am Surg 1998; 64:432-436
20. Gare M, Haviv YS, Ben-Yehuda A, Rubinger D, Bdolah-Abram T, Fuchs S, Gat O, Popovtzer MM, Gotsman MS, Mosseri M: The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography. J Am Coll Cardiol 1999; 34: 1682-1688
21. Spangberg-Viklund B, Berglund J, Nikonoff T, Nyberg P, Skau T, Larsson R: Does prophylactic treatment with felodopine, a calcium antagonist, prevent low-osmolar contrast-induced renal dysfunction in hydrated diabetic and nondiabetic patients with normal or moderately reduced renal function? Scand J Urol Nephrol 1996; 30: 63-68
22. Neumayer HH, Junge W, Kufner A, Wenning A : Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: A prospective randomized clinical trial. Nephrol Dial Transplant 1989; 4: 1030-1036
23. Wang A, Holcslaw T, Bashore TM, Freed MI, Miller D, Rudnick MR, Szerlip H, Thames MD, Davidson CJ, Shusterman N, Schwab SJ: Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int2000;57: 1675-1680
24. Koch JA, Plum J, Grabensee B, Modder U: Prostaglandin El: A new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media? Nephrol Dial Transplant 2000; 15: 43-49
25. Spargias K, Alexopoulos E, Kyrzopoulos S, Iokovis P, Greenwood DC, Manginas A, Voudris V, Pavlides G, Buller CE, Kremastinos D, Cokkinos DV: Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 2004; 110: 2837-2842
26. Vogt B, Ferrari P, Schonholzer C, Marti HP, Mohaupt M, Wiederkehr M, Cereghetti C, Serra A, Huynh-Do U, Uehlinger D, Frey FJ: Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 2001; 111: 692-698
27. Marenzi G, Marana I, Lauri G, Assanelli E, Grazi M, Campodonico J, Trabattoni D, Fabbiocchi F, Montorsi P, Bartorelli AL: The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 2003; 349: 1333-1340
28. Briguori C, Colombo A, Airoldi F, Violante A, Castelli A, Balestrieri P, Paolo Elia P, Golia B, Lepore S, Riviezzo G, Scarpato P, Librera M, Focaccio A, Ricciardelli B: N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity. J Am Coll Cardiol 2004; 44: 762-765
29. Tepel M, Zidek W: N-Acetylcysteine in nephrology: Contrast nephropathy and beyond. Opin Nephrol Hypertens 2004; 13: 649-654
30. Miner SE, Dzavik V, Nguyen-Ho P, Richardson R, Mitchell J, Atchison D, Seidelin P, Daly P, Ross J, McLaughlin PR, Ing D, Lewycky P, Barolet A, Schwartz L: N-acetylcysteine reduces contrast-associated nephro-pathy but not clinical events during long-term follow-up. Am Heart J 2004; 148: 690-695
31. Guru V, Fremes SE: The role of N-acetylcysteine in preventing radiographic contrast-induced nephropathy. Clin Nephrol2004;62: 77-83
32. Misra D, Leibowitz K, Gowda RM, Shapiro M, Khan IA: Role of N-acetylcysteine in prevention of contrast-induced nephropathy after cardiovascular procedures: A meta-analysis. Clin Cardiol 2004; 27: 607-610
33. Webb JG, Pate GE, Humphries KH, Buller CE, Shalansky S, Al Shamari A, Sutander A, Williams T, Fox RS, Levin A: A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: Lack of effect. Am Heart J 2004; 148: 422-429
34. Bader BD, Berger ED, Heede MB, Silberbaur I, Duda S, Risler T, Erley CM: What is the best hydration regimen to prevent contrast media-induced nephrotoxicity? Clin Nephrol2004; 62: 1-7